Filed: 2/17/2026ACC: 0002050709-26-000010
📋 What this filing means
SQUADRON CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 33 equity positions with a total reported market value of $235.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
33
Positions
$235.97M
Total AUM (reported)
26.06M
Total Shares
Allocation by class
COM$161.02M68.2%
COM NEW$32.55M13.8%
SPONSORED ADS$30.99M13.1%
ORDINARY SHARES$4.00M1.7%
CL A$3.04M1.3%
SHS$2.98M1.3%
ADS$1.40M0.6%
Portfolio Concentration
Top 3$80.37M34.1%
4–10$74.61M31.6%
11–25$68.61M29.1%
Rest$12.39M5.2%
Top 3 weight
34.1%
Top 10 weight
65.7%
Voting Authority Distribution
Total shares with voting rights: 26.06M
Sole
Full voting authority
25.55M
shares
% of voting shares98.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
515K
shares
% of voting shares2.0%
Investment Discretion (by position count)
Sole33
Shared0
Other0
Dominant voting typeSole · 98.0% of voting shares
Institutional Holdings33
Rows:
RELMADA THERAPEUTICS INC
SOLEShares6.70M
TypeSH
Market value$32.36M
13.71%
Sole
6.70M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares780K
TypeSH
Market value$27.71M
11.74%
Sole
780K
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares490K
TypeSH
Market value$20.30M
8.60%
Sole
490K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares145K
TypeSH
Market value$19.55M
8.29%
Sole
145K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares700K
TypeSH
Market value$11.30M
4.79%
Sole
700K
Shared
0.00
None
0.00
PALISADE BIO INC
SOLEShares4.50M
TypeSH
Market value$10.57M
4.48%
Sole
4.50M
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares350K
TypeSH
Market value$8.69M
3.68%
Sole
350K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares4.22M
TypeSH
Market value$8.66M
3.67%
Sole
4.22M
Shared
0.00
None
0.00
KODIAK SCIENCES INC
SOLEShares291.71K
TypeSH
Market value$8.16M
3.46%
Sole
291.71K
Shared
0.00
None
0.00
TERNS PHARMACEUTICALS INC
SOLEShares190K
TypeSH
Market value$7.68M
3.25%
Sole
190K
Shared
0.00
None
0.00
ARRIVENT BIOPHARMA INC
SOLEShares338K
TypeSH
Market value$6.80M
2.88%
Sole
0.00
Shared
0.00
None
338K
TARSUS PHARMACEUTICALS INC
SOLEShares80K
TypeSH
Market value$6.55M
2.78%
Sole
80K
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares230.65K
TypeSH
Market value$6.26M
2.65%
Sole
230.65K
Shared
0.00
None
0.00
SPRUCE BIOSCIENCES INC
SOLEShares70K
TypeSH
Market value$6.10M
2.58%
Sole
70K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares105.55K
TypeSH
Market value$4.73M
2.00%
Sole
105.55K
Shared
0.00
None
0.00
DBV TECHNOLOGIES S A
SOLEShares240K
TypeSH
Market value$4.60M
1.95%
Sole
240K
Shared
0.00
None
0.00
CYBIN INC
SOLEShares525K
TypeSH
Market value$4.29M
1.82%
Sole
525K
Shared
0.00
None
0.00
LIPOCINE INC NEW
SOLEShares530K
TypeSH
Market value$4.26M
1.80%
Sole
530K
Shared
0.00
None
0.00
BELITE BIO INC
SOLEShares26K
TypeSH
Market value$4.16M
1.76%
Sole
26K
Shared
0.00
None
0.00
GH RESEARCH PLC
SOLEShares315K
TypeSH
Market value$4.00M
1.70%
Sole
315K
Shared
0.00
None
0.00
EUPRAXIA PHARMACEUTICALS INC
SOLEShares500K
TypeSH
Market value$3.77M
1.60%
Sole
500K
Shared
0.00
None
0.00
VENTYX BIOSCIENCES INC
SOLEShares410K
TypeSH
Market value$3.70M
1.57%
Sole
410K
Shared
0.00
None
0.00
NEXTCURE INC
SOLEShares236.97K
TypeSH
Market value$3.36M
1.42%
Sole
236.97K
Shared
0.00
None
0.00
VERA THERAPEUTICS INC
SOLEShares60K
TypeSH
Market value$3.04M
1.29%
Sole
0.00
Shared
0.00
None
60K
WAVE LIFE SCIENCES LTD
SOLEShares175K
TypeSH
Market value$2.98M
1.26%
Sole
175K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
RELMADA THERAPEUTICS INCSOLE | COM | 6.70M | SH | $32.36M 13.71% | 6.70M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 780K | SH | $27.71M 11.74% | 780K | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 490K | SH | $20.30M 8.60% | 490K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 145K | SH | $19.55M 8.29% | 145K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 700K | SH | $11.30M 4.79% | 700K | 0.00 | 0.00 |
PALISADE BIO INCSOLE | COM | 4.50M | SH | $10.57M 4.48% | 4.50M | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 350K | SH | $8.69M 3.68% | 350K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 4.22M | SH | $8.66M 3.67% | 4.22M | 0.00 | 0.00 |
KODIAK SCIENCES INCSOLE | COM | 291.71K | SH | $8.16M 3.46% | 291.71K | 0.00 | 0.00 |
TERNS PHARMACEUTICALS INCSOLE | COM | 190K | SH | $7.68M 3.25% | 190K | 0.00 | 0.00 |
ARRIVENT BIOPHARMA INCSOLE | COM | 338K | SH | $6.80M 2.88% | 0.00 | 0.00 | 338K |
TARSUS PHARMACEUTICALS INCSOLE | COM | 80K | SH | $6.55M 2.78% | 80K | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 230.65K | SH | $6.26M 2.65% | 230.65K | 0.00 | 0.00 |
SPRUCE BIOSCIENCES INCSOLE | COM NEW | 70K | SH | $6.10M 2.58% | 70K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 105.55K | SH | $4.73M 2.00% | 105.55K | 0.00 | 0.00 |
DBV TECHNOLOGIES S ASOLE | SPONSORED ADS | 240K | SH | $4.60M 1.95% | 240K | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 525K | SH | $4.29M 1.82% | 525K | 0.00 | 0.00 |
LIPOCINE INC NEWSOLE | COM NEW | 530K | SH | $4.26M 1.80% | 530K | 0.00 | 0.00 |
BELITE BIO INCSOLE | SPONSORED ADS | 26K | SH | $4.16M 1.76% | 26K | 0.00 | 0.00 |
GH RESEARCH PLCSOLE | ORDINARY SHARES | 315K | SH | $4.00M 1.70% | 315K | 0.00 | 0.00 |
EUPRAXIA PHARMACEUTICALS INCSOLE | COM | 500K | SH | $3.77M 1.60% | 500K | 0.00 | 0.00 |
VENTYX BIOSCIENCES INCSOLE | COM | 410K | SH | $3.70M 1.57% | 410K | 0.00 | 0.00 |
NEXTCURE INCSOLE | COM NEW | 236.97K | SH | $3.36M 1.42% | 236.97K | 0.00 | 0.00 |
VERA THERAPEUTICS INCSOLE | CL A | 60K | SH | $3.04M 1.29% | 0.00 | 0.00 | 60K |
WAVE LIFE SCIENCES LTDSOLE | SHS | 175K | SH | $2.98M 1.26% | 175K | 0.00 | 0.00 |
Page 1 of 2